Showing 1531-1540 of 4131 results for "".
“Skin May Be Deep, But Dermatologists Are Superficial…”
https://practicaldermatology.com/topics/general-topics/skin-may-be-deep-but-dermatologists-are-superficial/21254/Recent Developments: What's Next for the Dermatology Pharmaceutical Industry?
https://practicaldermatology.com/columns/recent-developments/whats-next-for-the-dermatology-pharmaceutical-industry/21974/No doubt the dermatology pharmaceutical industry is undergoing a change. But what does it mean?Mycosis Fungoides: Diagnosis and Work-up of Early Stage Disease
https://practicaldermatology.com/topics/general-topics/mycosis-fungoides-diagnosis-and-work-up-of-early-stage-disease/22004/The ability to differentiate MF from mimickers permits early diagnosis and treatment, potentially improving long-term outcomes.Efficacy and Safety Outcomes for Adjuvant Immunotherapy Driving Guideline Recommendations for Stage III/IV Melanoma
https://practicaldermatology.com/programs/cme/efficacy-and-safety-outcomes-for-adjuvant-immunotherapy-driving-guideline-recommendations-for-stage-iiiiv-melanoma/36325/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Implementing Guideline-Concordant Care for a Patient With Newly Diagnosed Stage III Melanoma
https://practicaldermatology.com/programs/cme/implementing-guideline-concordant-care-for-a-patient-with-newly-diagnosed-stage-iii-melanoma/36326/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Data Driving Preferred Guideline Recommendations in First-Line Therapy for Metastatic Melanoma
https://practicaldermatology.com/programs/cme/data-driving-preferred-guideline-recommendations-in-first-line-therapy-for-metastatic-melanoma/36327/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Insights From Global Key Opinion Leaders on Regional Regulatory and Guideline Nuances to Optimize Melanoma Management
https://practicaldermatology.com/programs/cme/insights-from-global-key-opinion-leaders-on-regional-regulatory-and-guideline-nuances-to-optimize-melanoma-management/36331/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.June Issue: Melanoma Updates - Epidemiology, Diagnostics, and Treatment
https://practicaldermatology.com/issues/may-june-2025/melanoma-updates-epidemiology-diagnostics-and-treatment/35917/In this article, we review the latest changes in melanoma incidence and mortality, highlight key disparities among minority populations, and summarize emerging trends in technology and treatment that are reshaping the future of melanoma care.How to Use ChatGPT to Create a Social Media Content Calendar for Your Practice
https://practicaldermatology.com/topics/practice-management/how-to-use-chatgpt-to-create-a-social-media-content-calendar-for-your-practice/23968/ChatGPT can help you ideate content and post it with consistency.In the Pipeline: Clinical Trials
https://practicaldermatology.com/issues/october-2025/in-the-pipeline-clinical-trials/39765/Highlighting some of the clinical studies that began in 2025 for atopic dermatitis (AD) treatments.